Action News anchor Vanessa Vasconcelos sat down with Emergency Physician Doctor Rais Vohra to talk about viruses like the Flu ...

The monoclonal antibody nirsevimab, designed to mimic natural antibodies, significantly reduces severe RSV-related ...

Nirsevimab, a monoclonal antibody, is highly effective in real-world conditions at preventing severe respiratory syncytial ...

The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...

Germany's Robert Koch Institute (RKI) for infectious diseases has declared the country's RSV wave officially over. RSV, or ...

ACIP is recommending that adults aged 50 to 59 years who are at increased risk for severe RSV disease receive a single dose of an RSV vaccine.

HYDERABAD: Dr Reddy’s Laboratories on Monday said it has expanded its strategic partnership with French biopharma giant ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

She created a comic in 1999 entitled “The future as I see it” that foresaw a virus wreaking havoc upon the world in 2020, according to Japan Today. “Around 2020, an unknown virus will appear ...

On top of that, the company's second approved product -- a respiratory syncytial virus (RSV) vaccine -- brought in lower revenue than expected during its first quarters of commercialization.

The Department for Health and Social Care has broadened access to the life-saving jab this month to prevent these hospitalisations and the 8,000 deaths associated with respiratory syncytial virus ...

In August 2023, the FDA approved the company's maternal vaccine to prevent and protect infants from the respiratory syncytial virus from birth to six months of age. In October 2024, Pfizer ...